A Study of the Effectiveness of an Early Intervention on Adolescent Hazardous Gaming
Launched by SHANGHAI MENTAL HEALTH CENTER · Feb 4, 2025
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new mobile-based program designed to help teenagers who may be at risk of developing problems with excessive gaming, known as hazardous gaming. The goal is to see if this early intervention can effectively reduce gaming-related issues and improve overall well-being among adolescents.
To participate, young people aged between 14 and 17 who have been diagnosed with hazardous gaming can join the study, as long as they understand the purpose of the research and agree to take part. However, those with serious physical illnesses or intellectual disabilities, or those already diagnosed with a more severe gaming disorder, are not eligible. Participants will be guided through the program, which includes various activities and assessments to monitor their progress. This study aims to find out if early support can make a positive difference in the lives of teens struggling with gaming.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • (1) Clinical diagnosis of hazardous gaming defined in the ICD-11 (2) Fully comprehending the research's purpose and procedures and signing the informed consent
- Exclusion Criteria:
- • (1)Serious physical illness or intellectual disability (2) Clinical diagnosis of gaming disorder (3) Not completing all the interventions or assessments
About Shanghai Mental Health Center
Shanghai Mental Health Center is a leading institution dedicated to advancing mental health research and treatment. As a prominent clinical trial sponsor, the center focuses on innovative therapeutic approaches and evidence-based practices to address a wide range of psychiatric disorders. With a multidisciplinary team of experts and state-of-the-art facilities, the center is committed to enhancing patient care through rigorous clinical trials that contribute to the understanding and management of mental health conditions. Its mission is to foster collaboration among researchers, clinicians, and patients to promote mental well-being and improve outcomes in mental health care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shanghai, , China
Patients applied
Trial Officials
Na Zhong, MD
Study Chair
Shanghai Mental Health Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported